Tags
- A
- Accounts
- Adopted
- Adult
- Agent
- Alkylation
- An
- Antibody
- Antibody therapy
- Anticipation
- Approved
- Approximately
- Authorization
- Based on
- B cell
- B-cell lymphoma
- Bispecific monoclonal antibody
- CD20
- Challenge
- Challenges
- Chief
- Chief executive
- Chief executive officer
- Clinical
- Clinical endpoint
- Clinical trial
- Combination therapy
- Commission
- Committee for Medicinal Products for Human Use
- Complete
- Conditional
- Conditional marketing authorization
- Considered
- Data
- Diffuse large B-cell lymphoma
- Diffusion
- Disease
- Engaging
- European
- European Commission
- European Medicines Agency
- European Union
- Executive
- Executive officer
- Existence
- Follicle
- Follicular lymphoma
- Genmab
- Human subject research
- Indication
- Indoor Living
- Joanna van de Winkel
- Large-cell lymphoma
- Lines
- Lymphoma
- Marketing
- Marketing authorization
- Medicine
- Monoclonal
- Monoclonal antibody
- Monoclonal antibody therapy
- Most
- NASDAQ
- Need
- New
- NHL
- Officer
- Only
- Option
- Patient
- Pharmaceutical drug
- Phase
- PHD
- Poor
- Poor prognosis
- Positive
- Product
- Prognosis
- Progressed
- Recognize
- Refractory
- Relapse
- Represent
- Result
- Second
- Subcutaneous tissue
- Systemic
- Systemic therapy
- T cell
- The european
- The first
- Therapy
- Today
- Treat
- Trial
- Union
- Who
- Winkel